Current evidence of Chinese herbal constituents with effects on NMDA receptor blockade

Pharmaceuticals

Volumn 6, Issue 8, 2013, Pages 1039-1054

  Liang, Willmann ^a   Lam, Wai Ping ^a   Tang, Hong Chai ^a   Leung, Ping Chung ^a   Yew, David T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antagonist; Chinese medicine; Herb; NMDA receptor

Indexed keywords

ACHYRANTHES BIDENTATA POLYPEPTIDE; ACORUS TATARINOWII EXTRACT; ASARONE; BILOBALIDE; CHINESE DRUG; CURCUMIN; DONEPEZIL; GASTRODIN; GINKGOLIDE B; GINSENOSIDE; GLYCYRRHIZIC ACID; HUPERZINE A; IRIDOID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOTOGINSENOSIDE R1; NVP AAM 077; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYGALA TENUIFOLIA EXTRACT; POLYGALASAPONIN; POLYPEPTIDE; RIVASTIGMINE; RO 256981; SCROPHULARIA NINGPOENSIS EXTRACT; TENUIFOLIN; TENUIGENIN; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; ZIZIPHUS JUJUBE SPINOSA EXTRACT;

ACHYRANTHES BIDENTATA; ACORUS; ACORUS TATARINOWII; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHINESE HERB; COGNITION; COGNITIVE DEFECT; CONCENTRATION RESPONSE; CURCUMA LONGA; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG RESEARCH; DRUG SELECTIVITY; EVIDENCE BASED MEDICINE; GASTRODIA ELATA; GINKGO BILOBA; GINSENG; GLYCYRRHIZA URALENSIS; HEPATITIS; HUMAN; LYCOPODIUM; MEMORY DISORDER; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PANAX NOTOGINSENG; PARKINSON DISEASE; PHYTOCHEMISTRY; POLYGALA TENUIFOLIA; RECEPTOR UPREGULATION; REVIEW; SCROPHULARIA NINGPOENSIS; SCROPHULARIACEAE; SEIZURE; SENNA OBTUSIFOLIA; SIGNAL TRANSDUCTION; UNCARIA; UNCARIA RHYNCHOPHYLLA; ZIZIPHUS; ZIZIPHUS JUJUBE SPINOSA;

EID: 84882761039     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph6081039     Document Type: Review

References (91)

1. Rang, H.P.; Dale, M.M.; Ritter, J.M.; Flower, R.J. Rang and Dale's Pharmacology, 6th ed.; Elsevier: Philadelphia, PA, USA, 2007, pp. 480-485.
2. Ogden, K.K.; Traynelis, S.F. New advances in NMDA receptor pharmacology. Trend Pharmacol. Sci. 2011, 32, 726-733.
3. Kemp, J.A.; McKernan, R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. Suppl. 2002, 5, 1039-1042.
4. Dobrek, L.; Thor, P. Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system disease. Postepy. Hig. Med. Dosw. 2011, 65, 338-346.
5. Niesters, M.; Dahan, A. Pharmacokinetic and pharmacodynamics considerations for NMDA receptor antagonist in the treatment of chronic neuropathic pain. Expert Opin. Drug Metab. Toxicol. 2012, 8, 1409-1417.
6. Mathews, D.C.; Henter, I.D.; Zarate, C.A., Jr. Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs 2012, 72, 1313-1333.
7. Ghasemi, M.; Schachter, S.C. The NMDA receptor complex as a therapeutic target in epilepsy: A review. Epilepsy Behav. 2011, 22, 617-640.
8. Santangelo, R.M.; Acker, T.M.; Zimmerman, S.S.; Katzman, B.M.; Strong, K.L.; Traynelis, S.F.; Liotta, D.C. Novel NMDA receptor modulators: an update. Expert Opin. Ther. Patents 2012, 22, 1337-1352.
9. Paoletti, P.; Neyton, J. NMDA receptor subunits: Function and pharmacology. Curr. Opin Pharmacol. 2007, 7, 39-47.
10. Karakas, E.; Simorowski, N.; Furukawa, H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 2011, 475, 249-253.
11. Bettini, E.; Sava, A.; Griffante, C.; Carignani, C.; Buson, A.; Capelli, A.M.; Negri, M.; Andreetta, F.; Senar-Sancho, S.A; Guiral, L.; Cardullo, F. Identification and characterization of novel NMDA receptor antagonist selective for NR2A-over NR2B-containing receptors. J. Pharmacol. Exp. Ther. 2010, 335, 636-644.
12. Acker, T.M.; Yuan, H.; Hansen, K.B.; Vance, K.M.; Ogden, K.K.; Jensen, H.S.; Burger, P.B.; Mullasseril, P.; Snyder, J.P.; Liotta, D.C. Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol. Pharmacol. 2011, 80, 782-795.
13. Paoletti, P.; Perin-Dureau, F.; Fayyazuddin, A.; Le Goff, A.; Callebaut, I.; Neyton, J. Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron 2000, 28, 911-925.
14. Costa, B.M.; Irvine, M.W.; Fang, G.; Eaves, R.J.; Mayo-Martin, M.B.; Skifter, D.A.; Jane, D.E.; Monaghan, D.T. A novel family of negative and positive allosteric modulators of NMDA receptors. J. Pharmacol. Exp. Ther. 2010, 335, 614-621.
15. Hansen, K.B.; Traynelis, S.F. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J. Neurosci. 2011, 31, 3650-3661.
16. Paoletti, P.; Ascher, P.; Neyton, J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 1997, 17, 5711-5725.
17. Mott, D.D.; Doherty, J.J.; Zhang, S.; Washburn, M.S.; Fendley, M.J.; Lyuboslavsky, P.; Traynelis, S.F.; Dingledine, R. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat. Neurosci. 1998, 1, 659-667.
18. Choi, Y.B.; Lipton, S.A. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 1999, 23, 171-180.
19. Martinowich, K.; Jimenez, D.V.; Zarate, C.A., Jr.; Manji, H.K. Rapid antidepressant effects: moving right along. Mol. Psychiatry 2013, doi:10.1038/mp/2013.55.
20. Jin, R.; Clark, S.; Weeks, A.M.; Dudman, J.T.; Gouaux, E.; Partin, K.M. Mechanism of positive allosteric modulators acting on AMPA receptors. J. Neurosci. 2005, 25, 9027-9036.
21. Balannik, V.; Menniti, F.S.; Paternain, A.V.; Lerma, J.; Stern-Bach, Y. Molecular mechanism of AMPA receptor noncompetitive antagonism. Neuron 2005, 48, 279-288.
22. Wu, T.-Y.; Chen, C.-P.; Jinn, T.-R. Traditional Chinese medicines and Alzheimer's disease. Taiwan J. Obstet. Gynecol. 2011, 50, 131-135.
23. Jesky, R.; Hailong, C. Are herbal compounds the next frontier for alleviating learning and memory impairments? An integrative look at memory, dementia and the promising therapeutics of traditional Chinese medicines. Phytother. Res. 2011, 25, 1105-1118.
24. Chen, J.K.; Chen, T.T. Chinese Medical Herbology and Pharmacology; Art of Medicine Press: City of Industry, CA, USA, 2003; pp. 31-1074.
25. Matteucci, A.; Frank, C.; Domenici, M.R.; Balduzzi, M.; Paradisi, S.; Carnovale-Scalzo, D.; Scorcia, G.; Malchiodi-Albedi, F. Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D-aspartate-induced intracellular Ca2+ increase. Exp. Brain Res. 2005, 167, 641-648.
26. Swope, S.L.; Moss, S.J.; Raymond, L.A.; Huganir, R.L. Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 1999, 33, 49-78.
27. Lim, G.P.; Chu, T.; Yang, F.; Beech, W.; Frautschy, S.A.; Cole, G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2011, 21, 8370-8377.
28. Frautschy, S.A.; Hu, W.; Kim, P.; Miller, S.A.; Chu, T.; Harris-White, M.E.; Cole, G.M. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 2001, 22, 993-1005.
29. Ding, F.; Cheng, Q.; Gu, X. The repair effects of Achyranthes bidentata extract on the crushed common peroneal nerve of rabbits. Fitoterapia 2008, 79, 161-167.
30. Shen, H.; Yuan, Y.; Ding, F.; Liu, J.; Gu, X. The protective effects of Achyranthes bidentata polypeptides against NMDA-induced cell apoptosis in cultured hippocampal neurons through differential modulation of NR2A-and NR2B-containing NMDA receptors. Brain Res. Bull. 2008, 77, 274-281.
31. Shen, H.; Yuan, Y.; Ding, F.; Hu, N.; Liu, J.; Gu, X. Achyranthes bidentata polypeptides confer neuroprotection through inhibition of reactive oxygen species production, Bax expression, and mitochondrial dysfunction induced by overstimulation of N-methyl-D-aspartate receptors. J. Neurosci. Res. 2010, 88, 669-676.
32. Macdonald, J.F.; Xiong, Z.G.; Jackson, M.F. Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci. 2006, 29, 75-81.
33. Gordon, R.K.; Nigam, S.V.; Weitz, J.A.; Dave, J.R.; Doctor, B.P.; Ved, H.S. The NMDA receptor ion channel: A site for binding of huperzine A. J. Appl. Toxicol. 2001, 21, s47-s51.
34. Wang, R.; Yan, H.; Tang, X.C. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta. Pharmacol. Sin. 2006, 27, 1-26.
35. New Dietary Ingredients in Dietary Supplements-Background for Industry. Available online: http://www.fda.gov/food/dietarysupplements/ucm109764.htm/ (accessed on 6 August 2013).
36. Wang, R.; Tang, X.C. Neuroprotective effects of huperzine A: A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 2005, 14, 71-78.
37. Jiang, H.; Luo, X.; Bai, D. Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease. Curr. Med. Chem. 2003, 10, 2231-2252.
38. Gao, X.; Tang, X.C. Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J. Neurosci. Res. 2006, 83, 1048-1057.
39. Xiao, X.Q.; Zhang, H.Y.; Tang, X.C. Huperzine A attenuates amyloid β-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J. Neurosci. Res. 2002, 67, 30-36.
40. Wang, X.-D.; Zhang, J.-M.; Yang, H.-H.; Hu, G.-Y. Modulation of NMDA receptor by huperzine A in rat cerebral cortex. Acta. Pharmacol. Sin. 1999, 20, 31-35.
41. Zhang, J.-M.; Hu, G.-Y. Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons. Neurosci. 2011, 105, 663-669.
42. Gu, B.; Nakamichi, N.; Zhang, W.-S.; Nakamura, Y.; Kambe, Y.; Fukumori, R.; Takuma, K.; Yamada, K.; Takarada, T.; Taniura, H.; Yoneda, Y. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly. J. Neurosci. Res. 2009, 87, 2145-2156.
43. Lv, J.; Jia, H.; Jiang, Y.; Ruan, Y.; Liu, Z.; Yue, W.; Beyreuther, K.; Tu, P.; Zhang, D. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-β secretion in vitro. Acta. Physiol. 2009, 196, 419-425.
44. Jia, H.; Jiang, Y.; Ruan, Y.; Zhang, Y.; Ma, X.; Zhang, J.; Beyreuther, K.; Tu, P.; Zhang, D. Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid beta-protein in cultured cells. Neurosci. Lett. 2004, 367, 123-128.
45. Lee, H.J.; Ban, J.Y.; Koh, S.B. Polygalae radix extract protects cultured rat granule cells against damage induced by NMDA. Am. J. Chin. Med. 2004, 32, 599-610.
46. Xue, W.; Hu, J.F.; Yuan, Y.H.; Sun, J.D.; Li, B.Y.; Zhang, D.M.; Li, C.J.; Chen, N.H. Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory. Acta Pharmacol. Sin. 2009, 30, 1211-1219.
47. Yuching, W. Handbook of Commonly Used Chinese Herbal Prescriptions; Oriental Healing Arts Institute: Long Beach, CA, USA, 1983; p. 104.
48. Han, B.H.; Park, M.H. Folk Medicine; American Chemical Society: Washington, DC, USA, 1986; p. 205.
49. Huang, K.C. The Pharmacology of Chinese Herbs; CRC Press: Boca Raton, FL, USA, 1999; p. 155.
50. Yuan, C.L.; Wang, Z.B.; Jiao, Y.; Cao, A.M.; Huo, Y.L.; Cui, C.X. Sedative and hypnotic constituents of flavonoids in the seeds of Ziziphus spinosae. Chung Yao Tung Pao 1987, 12, 34-36+62-63.
51. Park, J.H.; Lee, H.J.; Koh, S.B.; Ban, J.Y.; Seong, Y.H. Protection of NMDA-induced neuronal cell damage by methanol extract of Zizyphi Spinosi Semen in cultured rat cerebellar granule cells. J. Ethnopharmaol. 2004, 95, 39-45.
52. Jacobo-Herrera, N.J.; Vartiainen, N.; Bremner, P.; Gibbons, S.; Koistinaho, J.; Heinrich, M. NF-ΚB modulators from Valeriana officinalis. Phytother. Res. 2006, 20, 917-919.
53. Houghton, P.J. The scientific basis for the reputed activity of valerian. J. Pharm. Pharmacol. 1999, 5, 505-512.
54. Del Valle-Mojica, L.M.; Ayala-Marin, Y.M.; Ortiz-Sanchez, C.M.; Torres-Hernandez, B.A.; Abdalla-Mukhaimer, S.; Ortiz, J.G. Selective interactions of Valeriana officinalis extracts and valerenic acid with [3H]glutamate binding to rat synaptic membranes. Evid. Based Complement. Alt. Med. 2011, 2011, 403-591.
55. Lee, J.; Son, D.; Lee, P.; Kim, S.-Y.; Kim, H.; Kim, C.-J.; Lim, E. Alkaloid fraction of Uncaria rhynchophylla protects against N-methyl-D-aspartate-induced apoptosis in rat hippocampal slices. Neurosci. Lett. 2003, 348, 51-55.
56. Fujiwara, H.; Iwasaki, K.; Furukawa, K.; Seki, T.; He, M.; Maruyama, M.; Tomita, N.; Kudo, Y.; Higuchi, M.; Saido, T.C. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins. J. Neurosci. Res. 2006, 84, 427-433.
57. Lee, J.; Son, D.; Lee, P.; Kim, D.-K.; Shin, M.-C.; Jang, M.-H.; Kim, C.-J.; Kim, Y.-S.; Kim, S.-Y.; Kim, H. Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-D-aspartate in rat hippocampus. J. Pharmacol. Sci. 2003, 92, 70-73.
58. Sun, X.; Chan, L.N.; Gong, X.; Sucher, N.J. N-methyl-D-aspartate receptor antagonist activity in traditional Chinese stroke medicines. Neurosignals 2003, 12, 31-38.
59. Kang, T.H.; Murakami, Y.; Matsumoto, K.; Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H. Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 2002, 455, 27-34.
60. Mathern, G.W.; Pretorius, J.K.; Kornblum, H.I.; Mendoza, D.; Lozada, A.; Leite, J.P.; Chimelli, L.M.C.; Fried, I.; Sakamoto, A.C.; Assirati, J.A. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain 1997, 120, 1937-1959.
61. Xu, X.; Lu, Y, Bie, X. Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta. Med. 2007, 73, 650-654.
62. Huang, J.H. Comparison studies on pharmacological properties of injected gastrodia elata, gastrodin-free fraction and gastrodin. Zhong Guo Yi Xue Ke Xue Yuan Xue Bao 1989, 11, 147-150.
63. Baek, N.I.; Choi, S.Y.; Park, J.K.; Cho, S.W.; Ahn, E.M.; Jeon, S.G.; Lee, B.R.; Bahn, J.H.; Kim, Y.K.; Shon, I.H. Isolation and identification of succinic semialdehyde dehydrogenase inhibitory compound from the rhizome of Gastrodia elata Blume. Arch. Pharm. Res. 1999, 22, 219-224.
64. Zeng, X.; Zhang, S.; Zhang, L.; Zhang, K.; Zheng, X. A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro. Planta Med. 2006, 72, 1359-1365.
65. An, S.J.; Park, S.K.; Hwang, I.K.; Choi, S.Y.; Kim, S.K.; Kwon, O.S.; Jung, S.J.; Baek, N.I.; Lee, H.Y.; Won, M.H.; Kang, T.C. Gastrodin decreases immunoreactivities of gamma-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils. J. Neurosci. Res. 2003, 71, 534-543.
66. Kumar, H.; Kim, I.S.; More, S.V.; Kim, B.W.; Bahk, Y.Y.; Choi, D.K. Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evid. Based Complement. Alternat. Med. 2013, 2013, 514095.
67. Kim, D.S.H.L.; Kim, J.-Y.; Han, Y.-S. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from β-amyloid(1-42) insult. J. Alt. Complement. Med. 2007, 13, 333-340.
68. Guo, H.; Chang, Z.; Yang, R.; Guo, D.; Zheng, J. Anthraquinones from hairy root cultures of cassia obtusifolia. Phytochemistry 1998; 49, 1623-1625.
69. Kim, D.H.; Yoon, B.H.; Kim, Y.M.; Lee, S.; Shin, B.Y.; Jung, J.W.; Kim, H.J.; Lee, Y.S.; Choi, J.S.; Kim, S.Y. The seed extract of cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J. Pharmacol. Sci. 2007, 105, 82-93.
70. Drever, B.D.; Anderson, W.G.L.; Riedel, G.; Kim, D.H.; Ryu, J.H.; Choi, D.-Y.; Platt, B. The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. J. Pharmacol. Sci. 2008, 107, 380-392.
71. Thibault, O.; Porter, N.M.; Chen, K.C.; Blalock, E.M.; Kaminker, P.G.; Clodfelter, G.V.; Brewer, L.D.; Landfield, P.W. Calcium dysregulation in neuronal aging and Alzheimer's disease: History and new directions. Cell Calcium 1998, 24, 417-433.
72. Cho, J.; Joo, N.E.; Kong, J.-Y.; Jeong, D.-Y.; Lee, K.D.; Kang, B.-S. Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizome in cultured rat cortical neurons. J. Ethnopharmacol. 2000; 73, 31-37.
73. Cho, J.; Kong, J.-Y.; Jeong, D.-Y.; Lee, K.D.; Lee, D.U.; Kang, B.-S. NMDA receptor-mediated neuroprotection by essential oils from rhizomes of Acorus gramineus. Life Sci. 2001, 68, 1567-1573.
74. Irie, Y.; Keung, W.M. Rizhoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-β peptide. Brain Res. 2003, 963, 282-289.
75. Limon, D., Mendieta, L., Diaz, A.; Chamorro, G.; Espinosa, B.; Zenteno, E.; Guevara, J. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta(25-35). Neurosci. Lett. 2009, 453, 98-103.
76. Cho, J.; Kim, Y.H.; Kong, J.Y.; Yang, C.H.; Park, C.G. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci. 2002, 71, 591-599.
77. Cherng, J.-M.; Lin, H.-J.; Hung, M.S.; Lin, Y.-R.; Chan, M.-H.; Lin, J.-C. Inhibition of nuclear factor ΚB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. Eur. J. Pharmacol. 2006, 547, 10-21.
78. Van Rossum, T.G.; Vulto, A.G.; Hop, W.C.; Brouwer, J.T.; Niesters, H.G.; Schalm, S.W. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial. J. Gastroenterol. Hepatol. 1999, 14, 1093-1099.
79. Kim, S.; Kim, T.; Ahn, K.; Park, W.-K.; Nah, S.-Y.; Rhim, H. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem. Biophys. Res. Comm. 2004, 323, 416-424.
80. Kim, S.; Ahn, K.; Oh, T.H.; Nah, S-Y.; Rhim, H. Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem. Biophys. Res. Comm. 2002, 296, 247-254.
81. Radad, K.; Gille, G.; Moldzio, R.; Saito, H.; Rausch, W.-D. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 2004, 1021, 41-53.
82. Lee, E.; Kim, S.; Chung, K.C.; Choo, M.-K.; Kim, D.-H.; Nan, G.; Rhim, H. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur. J. Pharmacol. 2006, 53, 69-77.
83. Birks, J.; Grimley, E.J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007, 2007, CD003120.
84. Le Bars, P.L.; Katz, M.M.; Berman, N.; Itil, T.M.; Freedman, A.M.; Schatzberg, A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American Egb study group. JAMA 1997, 278, 1327-1332.
85. Li, S.; Luo, J.; Wang, X.; Guan, B.-C.; Sun, C.-K. Effects of Ginkgo biloba extracts on NMDA-activated currents in acutely isolated hippocampal neurons of the rat. Phytother. Res. 2011, 25, 137-141.
86. Ahlemeyer, B.; Krieglstein, J. Neuroprotective effects of Ginkgo biloba extract. Cell. Mol. Life Sci. 2003, 60, 1779-1782.
87. Weichel, O.; Hilger, M.; Chatterjee, S.S.; Lehr, M.; Klein, J. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 360, 609-615.
88. Lu, G.; Wu, Y.; Mak, Y.T., Wai, S.M.; Feng, Z.T.; Rudd, J.A.; Yew, D.T. Molecular evidence of the neuroprotective effect of Ginkgo biloba (EGb761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8. Brain Res. 2006, 1090, 23-28.
89. Kim, S.R.; Kim, Y.C. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana. Phytochemistry 2000, 54, 503-509.
90. Kim, S.R.; Lee, K.Y.; Koo, K.A.; Sung, S.H.; Lee, N.; Kim, J.; Kim, Y.C. Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots. J. Nat. Prod. 2002, 65, 1696-1699.
91. Kim, S.R.; Koo, K.A.; Sung, S.H.; Ma, C.J.; Yoon, J.S.; Kim, Y.C. Iridoids from Scrophularia buergeriana attenuate glutamate-induced neurotoxicity in rat cortical cultures. J. Neurosci. Res. 2003, 74, 948-955.